Actithera

Oslo, Norway

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

$75.5M raised

Jul 2025

Series A

Top Investors

Sofinnova PartnersInnovestorHadean Ventures4BIO CapitalInvestinor

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Actithera raised?

Actithera has raised $75.5M in total funding. The most recent round was Series A. The last funding was announced in July 2025.

Who are Actithera's investors?

Actithera's investors include Sofinnova Partners, Innovestor, Hadean Ventures, 4BIO Capital, Investinor.

Where is Actithera headquartered?

Actithera is headquartered in Oslo, Norway.

What does Actithera do?

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

What stage is Actithera at?

Actithera is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 9, 2025.

MLA

"Actithera — Funding & Investors." VCBacked, July 9, 2025, https://www.vcbacked.co/company/actithera. Accessed June 17, 2026.

APA

VCBacked. (2025). Actithera — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/actithera

Wikipedia (cite web)

{{cite web |title=Actithera — Funding & Investors |url=https://www.vcbacked.co/company/actithera |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 9, 2025.